227 related articles for article (PubMed ID: 32532259)
1. Evaluation of treatment with a combination of mycophenolate mofetil and prednisolone in dogs with meningoencephalomyelitis of unknown etiology: a retrospective study of 86 cases (2009-2017).
Song JH; Yu DH; Lee HC; Hwang TS; Kim YJ; An SJ; Jung DI
BMC Vet Res; 2020 Jun; 16(1):192. PubMed ID: 32532259
[TBL] [Abstract][Full Text] [Related]
2. Retrospective evaluation of combined mycophenolate mofetil and prednisone treatment for meningoencephalomyelitis of unknown etiology in dogs: 25 cases (2005-2011).
Barnoon I; Shamir MH; Aroch I; Bdolah-Abram T; Srugo I; Konstantin L; Chai O
J Vet Emerg Crit Care (San Antonio); 2016; 26(1):116-24. PubMed ID: 26458162
[TBL] [Abstract][Full Text] [Related]
3. Retrospective evaluation of prognosis and survival with various immunosuppressants in 82 dogs diagnosed with meningoencephalitis of unknown etiology (2010-2021).
Kim SH; Oh YI; Park SM; An JH; Kim TH; Kim SS; Ah JG; Seo KW; Youn HY
BMC Vet Res; 2023 Dec; 19(1):269. PubMed ID: 38087262
[TBL] [Abstract][Full Text] [Related]
4. Treatment of 11 dogs with meningoencephalomyelitis of unknown origin with a combination of prednisolone and cytosine arabinoside.
Menaut P; Landart J; Behr S; Lanore D; Trumel C
Vet Rec; 2008 Feb; 162(8):241-5. PubMed ID: 18296666
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of treatment with a combination of azathioprine and prednisone in dogs with meningoencephalomyelitis of undetermined etiology: 40 cases (2000-2007).
Wong MA; Hopkins AL; Meeks JC; Clarke JD
J Am Vet Med Assoc; 2010 Oct; 237(8):929-35. PubMed ID: 20946080
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two regimens for the treatment of meningoencephalomyelitis of unknown etiology.
Smith PM; Stalin CE; Shaw D; Granger N; Jeffery ND
J Vet Intern Med; 2009; 23(3):520-6. PubMed ID: 19645837
[TBL] [Abstract][Full Text] [Related]
7. Survival time and relapse in dogs with meningoencephalomyelitis of unknown origin treated with prednisolone and ciclosporin: a retrospective study.
Brady SL; Woodward AP; le Chevoir M
Aust Vet J; 2020 Oct; 98(10):491-498. PubMed ID: 32794230
[TBL] [Abstract][Full Text] [Related]
8. Treatment of canine meningoencephalomyelitis of unknown aetiology with mycophenolate mofetil and corticosteroids: 25 cases (2007-2012).
Woolcock AD; Wang A; Haley A; Kent M; Creevy KE; Platt SR
Vet Med Sci; 2016 May; 2(2):125-135. PubMed ID: 29067186
[TBL] [Abstract][Full Text] [Related]
9. A retrospective evaluation of the steroid sparing effects of oral mycophenolate mofetil (MMF) as an adjunct immunosuppressant for the treatment of canine pemphigus foliaceus.
Putra A; Austel M; Banovic F
Vet Dermatol; 2022 Feb; 33(1):77-e24. PubMed ID: 34697841
[TBL] [Abstract][Full Text] [Related]
10. Procarbazine as adjunctive therapy for treatment of dogs with presumptive antemortem diagnosis of granulomatous meningoencephalomyelitis: 21 cases (1998-2004).
Coates JR; Barone G; Dewey CW; Vitale CL; Holloway-Azene NM; Sessions JK
J Vet Intern Med; 2007; 21(1):100-6. PubMed ID: 17338156
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of the combination of glucocorticoids, mycophenolate-mofetil and human immunoglobulin for the therapy of immune mediated haemolytic anaemia in dogs].
Oggier D; Tomsa K; Mevissen M; Glaus T
Schweiz Arch Tierheilkd; 2018 Mar; 160(3):171-178. PubMed ID: 29509140
[TBL] [Abstract][Full Text] [Related]
12. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).
Wang A; Smith JR; Creevy KE
J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827
[TBL] [Abstract][Full Text] [Related]
13. Unsuccessful cyclosporine plus prednisolone therapy for autoimmune meningoencephalitis in three dogs.
Jung DI; Lee HC; Ha J; Jung HW; Jeon JH; Moon JH; Lee JH; Kim NH; Sur JH; Kang BT; Cho KW
J Vet Med Sci; 2013 Dec; 75(12):1661-5. PubMed ID: 23955394
[TBL] [Abstract][Full Text] [Related]
14. Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogs.
Zarfoss M; Schatzberg S; Venator K; Cutter-Schatzberg K; Cuddon P; Pintar J; Weinkle T; Scarlett J; Delahunta A
J Small Anim Pract; 2006 Oct; 47(10):588-95. PubMed ID: 17004951
[TBL] [Abstract][Full Text] [Related]
15. Use of mycophenolate mofetil to treat immune-mediated skin disease in 14 dogs - a retrospective evaluation.
Ackermann AL; May ER; Frank LA
Vet Dermatol; 2017 Apr; 28(2):195-e44. PubMed ID: 27943548
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation, diagnostic findings, prognostic factors, treatment and outcome in dogs with meningoencephalomyelitis of unknown origin: A review.
Cornelis I; Van Ham L; Gielen I; De Decker S; Bhatti SFM
Vet J; 2019 Feb; 244():37-44. PubMed ID: 30825893
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.
Zachou K; Gatselis N; Papadamou G; Rigopoulou EI; Dalekos GN
J Hepatol; 2011 Sep; 55(3):636-646. PubMed ID: 21238519
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2008).
Dewey CW; Cerda-Gonzalez S; Fletcher DJ; Harb-Hauser MF; Levine JM; Badgley BL; Olby NJ; Shelton GD
J Am Vet Med Assoc; 2010 Mar; 236(6):664-8. PubMed ID: 20225980
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil as a treatment for presumed idiopathic chronic hepatitis in dogs: Six cases (2010-2022).
Beehler MK; Kearns SA; Crouse ZJ
Vet Med Sci; 2023 Nov; 9(6):2527-2533. PubMed ID: 37659075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
